A 10521 New York 2025-2026 session
Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state
Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state; requires tests be made available within twelve months.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
In committee — last recorded action April 7, 2026
PRINT NUMBER 10521A
Passage likelihood
34% Comparable to other bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 20% of introduced state bills are enacted.
- Current stage Referred to committee.
- Cosponsors 7 cosponsors.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- PRINT NUMBER 10521A
- AMEND AND RECOMMIT TO HEALTH
- REFERRED TO HEALTH